IBL Healthcare Ltd.

  • Market Cap: Small Cap
  • Industry: Retailing
  • ISIN: PK0095501018
PKR
55.95
-0.47 (-0.83%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 18.71%

 
2

Flat results in Mar 25

3

Risky -

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Retailing

stock-summary
Market cap

PKR 3,678 Million (Small Cap)

stock-summary
P/E

24.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.14

stock-summary
Return on Equity

8.81%

stock-summary
Price to Book

1.51

Revenue and Profits:
Net Sales:
971 Million
(Quarterly Results - Dec 2025)
Net Profit:
36 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
50.48%
0%
50.48%
6 Months
28.86%
0%
28.86%
1 Year
69.55%
0%
69.55%
2 Years
112.2%
0%
112.2%
3 Years
80.04%
0%
80.04%
4 Years
-25.17%
0%
-25.17%
5 Years
29.32%
0%
29.32%

IBL Healthcare Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
8.11%
EBIT Growth (5y)
3.14%
EBIT to Interest (avg)
10.43
Debt to EBITDA (avg)
1.92
Net Debt to Equity (avg)
0.15
Sales to Capital Employed (avg)
1.55
Tax Ratio
79.85%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
18.71%
ROE (avg)
12.45%

Valuation key factors

Factor
Value
P/E Ratio
24
Industry P/E
Price to Book Value
2.17
EV to EBIT
12.31
EV to EBITDA
12.06
EV to Capital Employed
2.21
EV to Sales
1.15
PEG Ratio
0.02
Dividend Yield
NA
ROCE (Latest)
17.92%
ROE (Latest)
8.97%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -13.36% vs -4.83% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -48.49% vs -4.39% in Sep 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "971.10",
          "val2": "1,120.90",
          "chgp": "-13.36%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "94.20",
          "val2": "123.80",
          "chgp": "-23.91%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "12.00",
          "val2": "9.20",
          "chgp": "30.43%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "35.90",
          "val2": "69.70",
          "chgp": "-48.49%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "93.60%",
          "val2": "108.50%",
          "chgp": "-1.49%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Jun'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Jun 2025 is 19.96% vs -10.54% in Jun 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Jun 2025 is 2,642.11% vs -97.54% in Jun 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4,322.50",
          "val2": "3,603.40",
          "chgp": "19.96%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "423.50",
          "val2": "82.00",
          "chgp": "416.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "60.20",
          "val2": "67.40",
          "chgp": "-10.68%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-10.10",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "208.40",
          "val2": "7.60",
          "chgp": "2,642.11%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "96.10%",
          "val2": "20.70%",
          "chgp": "7.54%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQstock-summary

Dec'25
Sep'25
Change(%)
Net Sales
971.10
1,120.90
-13.36%
Operating Profit (PBDIT) excl Other Income
94.20
123.80
-23.91%
Interest
12.00
9.20
30.43%
Exceptional Items
0.00
0.00
Consolidate Net Profit
35.90
69.70
-48.49%
Operating Profit Margin (Excl OI)
93.60%
108.50%
-1.49%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2025 is -13.36% vs -4.83% in Sep 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2025 is -48.49% vs -4.39% in Sep 2025

Annual Results Snapshot (Consolidated) - Jun'25stock-summary

Jun'25
Jun'24
Change(%)
Net Sales
4,322.50
3,603.40
19.96%
Operating Profit (PBDIT) excl Other Income
423.50
82.00
416.46%
Interest
60.20
67.40
-10.68%
Exceptional Items
0.00
-10.10
100.00%
Consolidate Net Profit
208.40
7.60
2,642.11%
Operating Profit Margin (Excl OI)
96.10%
20.70%
7.54%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Jun 2025 is 19.96% vs -10.54% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Jun 2025 is 2,642.11% vs -97.54% in Jun 2024

stock-summaryCompany CV
About IBL Healthcare Ltd. stock-summary
stock-summary
IBL Healthcare Ltd.
Retailing
IBL HealthCare Limited is a Pakistan-based company engaged in marketing, selling and distribution of healthcare products. The Company is engaged in providing a range of healthcare and nutritional products. The Company's divisions include Mead Johnson Nutrition, Nestle Health Science, Brand Plus, Medical Disposable Division and Principle Health Care. The Mead Johnson Nutrition division offers approximately 70 products, such as Enfamama A+, Enfamil A+ Stage 1, Enfamil A+ Stage 2, Enfagrow A+ Stage 3 and Sustagen school 6+. Nestle Health Science offers nutritional solutions for people with specific dietary needs related to illnesses, disease states or the challenges of different life stages. It offers products, such as Resource Diabetes and Resource Optimum. The Brand Plus division provides a range of baby cereals. The Medical Disposable division consist a range of medical disposables. The Principle Health Care division is a vitamin, mineral and food supplement producer.
Company Coordinates stock-summary
Company Details
9th Floor, N.I.C. Building, Abbasi Shaheed Road KARACHI None : 75530
stock-summary
Tel: 92 21 37170200
stock-summary
Registrar Details